<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Glans I</submitter><funding>GHR Foundation</funding><funding>Vetenskapsrådet</funding><funding>Knut and Alice Wallenberg Foundation</funding><funding>Cure Alzheimer&amp;amp;apos;s Fund</funding><funding>Stiftelsen Bundy Academy</funding><funding>Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse</funding><funding>Skåne University Hospital Lund</funding><funding>GE Healthcare</funding><funding>Greta och Johan Kocks stiftelser</funding><funding>National Institute on Aging</funding><funding>Parkinsonfonden</funding><funding>Michael J Fox Foundation for Parkinson&amp;amp;apos;s Research</funding><funding>Roche</funding><funding>European Research Council</funding><funding>Hjärnfonden</funding><funding>Alzheimer&amp;amp;apos;s Association</funding><funding>Alzheimerfonden</funding><funding>Lunds Universitet</funding><pagination>100448</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12869030</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(2)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>The global prevalence of dementia is rapidly expanding and is expected to triple by 2050. Approximately 45 % of dementia cases are estimated to be attributable to potentially modifiable risk factors. Identifying how these factors contribute to specific brain pathologies may improve strategies to reduce dementia incidence.&lt;h4>Objectives, design, setting&lt;/h4>The aim of this study was to identify both non-modifiable and modifiable risk factors associated with longitudinal changes in white matter hyperintensities (WMH), amyloid-beta (Aβ) and tau. Data were acquired in the prospective observational Swedish BioFINDER-2 study between May 2017-January 2025. All participants underwent clinical assessments, questionnaires and at least two magnetic resonance imaging (MRI), Aβ Posit</pubmed_abstract><journal>The journal of prevention of Alzheimer's disease</journal><pubmed_title>Associations of modifiable and non-modifiable risk factors with longitudinal white matter hyperintensities, amyloid-β and tau - a prospective cohort study.</pubmed_title><pmcid>PMC12869030</pmcid><funding_grant_id>AF-1,011799</funding_grant_id><funding_grant_id>2020-O000028</funding_grant_id><funding_grant_id>SG-23\u20131,061717</funding_grant_id><funding_grant_id>WASP/DDLS22\u2013066</funding_grant_id><funding_grant_id>ERAPERMED2021\u2013184</funding_grant_id><funding_grant_id>2018-02052</funding_grant_id><funding_grant_id>AF-980907</funding_grant_id><funding_grant_id>2021-00905</funding_grant_id><funding_grant_id>101096455</funding_grant_id><funding_grant_id>2017-0383</funding_grant_id><funding_grant_id>FO2021\u20130293</funding_grant_id><funding_grant_id>ZEN24\u20131,069572</funding_grant_id><funding_grant_id>AF-981132</funding_grant_id><funding_grant_id>MJFF-025507</funding_grant_id><funding_grant_id>2022-00775</funding_grant_id><funding_grant_id>AF-968598</funding_grant_id><funding_grant_id>FO2022\u20130204</funding_grant_id><funding_grant_id>2017-01541</funding_grant_id><funding_grant_id>ADG- 101096455</funding_grant_id><funding_grant_id>FO2023\u20130163</funding_grant_id><funding_grant_id>ALZSI-26\u20131,523522</funding_grant_id><funding_grant_id>FO2024\u20130284</funding_grant_id><funding_grant_id>2021-02219</funding_grant_id><funding_grant_id>FO2025\u20130055</funding_grant_id><funding_grant_id>AF-1,011949</funding_grant_id><funding_grant_id>1280/20</funding_grant_id><funding_grant_id>1412/22</funding_grant_id><funding_grant_id>2022-0231</funding_grant_id><pubmed_authors>Strandberg O</pubmed_authors><pubmed_authors>Palmqvist S</pubmed_authors><pubmed_authors>Hansson O</pubmed_authors><pubmed_authors>van Westen D</pubmed_authors><pubmed_authors>Glans I</pubmed_authors><pubmed_authors>Mattsson-Carlgren N</pubmed_authors><pubmed_authors>Spotorno N</pubmed_authors><pubmed_authors>Stomrud E</pubmed_authors><pubmed_authors>Ossenkoppele R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Associations of modifiable and non-modifiable risk factors with longitudinal white matter hyperintensities, amyloid-β and tau - a prospective cohort study.</name><description>&lt;h4>Background&lt;/h4>The global prevalence of dementia is rapidly expanding and is expected to triple by 2050. Approximately 45 % of dementia cases are estimated to be attributable to potentially modifiable risk factors. Identifying how these factors contribute to specific brain pathologies may improve strategies to reduce dementia incidence.&lt;h4>Objectives, design, setting&lt;/h4>The aim of this study was to identify both non-modifiable and modifiable risk factors associated with longitudinal changes in white matter hyperintensities (WMH), amyloid-beta (Aβ) and tau. Data were acquired in the prospective observational Swedish BioFINDER-2 study between May 2017-January 2025. All participants underwent clinical assessments, questionnaires and at least two magnetic resonance imaging (MRI), Aβ Posit</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Feb</publication><modification>2026-07-15T13:18:02.236Z</modification><creation>2026-07-05T03:08:27.702Z</creation></dates><accession>S-EPMC12869030</accession><cross_references><pubmed>41478835</pubmed><doi>10.1016/j.tjpad.2025.100448</doi></cross_references></HashMap>